The effect of insulin therapy on beta-cell survival in patients with Maturity Onset Diabetes of the Young ( MODY) 3. A 2 year, single-centre, open-label, randomised, parallel-group trial comparing insulin therapy to conventional oral sulphonyurea on beta-cell survival.
Phase of Trial: Phase II
Latest Information Update: 05 Aug 2011
At a glance
- Drugs Insulin aspart (Primary) ; Insulin detemir (Primary) ; Gliclazide
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 05 Aug 2011 New trial record